photo free
Home Images Vectors Videos

Stock image Cardiovascular Risk Reduction

stock image Pencil with eraser

Pencil With Eraser

Image, 0.65MB, 4288 × 2848 jpg
stock image Food products recommended for stabilizing insulin and blood sugar levels. DIabetes diet

Food Products Recommended For Stabilizing Insulin And Blood Sugar Levels. DIabetes Diet

Image, 7.88MB, 8256 × 5125 jpg
stock image Food products recommended for stabilizing insulin and blood sugar levels. DIabetes diet

Food Products Recommended For Stabilizing Insulin And Blood Sugar Levels. DIabetes Diet

Image, 11.08MB, 8256 × 4872 jpg
stock image Food products recommended for stabilizing insulin and blood sugar levels. DIabetes diet

Food Products Recommended For Stabilizing Insulin And Blood Sugar Levels. DIabetes Diet

Image, 10.47MB, 4952 × 7056 jpg
stock image Foods enhancing the risk of cancer. Junk food

Foods Enhancing The Risk Of Cancer. Junk Food

Image, 11.91MB, 8256 × 5504 jpg
stock image Food products recommended for stabilizing insulin and blood sugar levels. DIabetes diet

Food Products Recommended For Stabilizing Insulin And Blood Sugar Levels. DIabetes Diet

Image, 8MB, 8256 × 5136 jpg
stock image Food products recommended for stabilizing insulin and blood sugar levels. DIabetes diet

Food Products Recommended For Stabilizing Insulin And Blood Sugar Levels. DIabetes Diet

Image, 8.57MB, 8376 × 4120 jpg
stock image Foods enhancing the risk of cancer. Junk food

Foods Enhancing The Risk Of Cancer. Junk Food

Image, 12.08MB, 8256 × 5504 jpg
stock image Foods enhancing the risk of cancer. Junk food

Foods Enhancing The Risk Of Cancer. Junk Food

Image, 13.43MB, 5504 × 8256 jpg
stock image Foods enhancing the risk of cancer. Junk food

Foods Enhancing The Risk Of Cancer. Junk Food

Image, 11.1MB, 8256 × 5504 jpg
stock image Foods enhancing the risk of cancer. Junk food

Foods Enhancing The Risk Of Cancer. Junk Food

Image, 10.98MB, 8256 × 4368 jpg
stock image Prague, Czech Republic - July 10 2024: XIGDUO box of medication with DAPAGLIFLOZIN and METFORMIN active substances by ASTRAZENECA, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.24MB, 4032 × 3024 jpg
stock image Prague, Czech Republic - July 10 2024: JARDIANCE box of medication with EMPAGLIFLOZIN active substance by BOEHRINGER INGELHEIM, used for treatment of type 2 diabetes and cardiovascular risk reduction.

Prague, Czech Republic - July 10 2024: JARDIANCE Box Of Medication With EMPAGLIFLOZIN Active Substance By BOEHRINGER INGELHEIM, Used For Treatment Of Type 2 Diabetes And Cardiovascular Risk Reduction.

Image, 2.06MB, 3024 × 4032 jpg
stock image Prague, Czech Republic - July 10 2024: XIGDUO box of medication with DAPAGLIFLOZIN and METFORMIN active substances by ASTRAZENECA, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.47MB, 4032 × 3024 jpg
stock image Prague, Czech Republic - July 10 2024: XIGDUO box of medication with DAPAGLIFLOZIN and METFORMIN active substances by ASTRAZENECA, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.54MB, 4032 × 3024 jpg
stock image Prague, Czech Republic - July 10 2024: JARDIANCE box of medication with EMPAGLIFLOZIN active substance by BOEHRINGER INGELHEIM, used for treatment of type 2 diabetes and cardiovascular risk reduction.

Prague, Czech Republic - July 10 2024: JARDIANCE Box Of Medication With EMPAGLIFLOZIN Active Substance By BOEHRINGER INGELHEIM, Used For Treatment Of Type 2 Diabetes And Cardiovascular Risk Reduction.

Image, 2.06MB, 3024 × 4032 jpg
stock image Prague, Czech Republic - July 10 2024: XIGDUO box of medication with DAPAGLIFLOZIN and METFORMIN active substances by ASTRAZENECA, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.37MB, 4032 × 3024 jpg
stock image Prague, Czech Republic - July 10 2024: XIGDUO box of medication with DAPAGLIFLOZIN and METFORMIN active substances by ASTRAZENECA, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.27MB, 4032 × 3024 jpg
stock image July 1, 2024, Paraguay. In this photo illustration, antibiotic tablets (amoxicillin and norfloxacin), activated charcoal and flu medicine are seen next to a measuring tape. Some medications can cause side effects that, over time, can cause weight gai

July 1, 2024, Paraguay. In This Photo Illustration, Antibiotic Tablets (amoxicillin And Norfloxacin), Activated Charcoal And Flu Medicine Are Seen Next To A Measuring Tape. Some Medications Can Cause Side Effects That, Over Time, Can Cause Weight Gai

Image, 13.51MB, 4830 × 3220 jpg
stock image Prague, Czech Republic - July 10 2024: XIGDUO box of medication with DAPAGLIFLOZIN and METFORMIN active substances by ASTRAZENECA, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.31MB, 3024 × 4032 jpg
stock image Prague, Czech Republic - July 10 2024: JARDIANCE box of medication with EMPAGLIFLOZIN active substance by BOEHRINGER INGELHEIM, used for treatment of type 2 diabetes and cardiovascular risk reduction.

Prague, Czech Republic - July 10 2024: JARDIANCE Box Of Medication With EMPAGLIFLOZIN Active Substance By BOEHRINGER INGELHEIM, Used For Treatment Of Type 2 Diabetes And Cardiovascular Risk Reduction.

Image, 2.1MB, 4032 × 3024 jpg
stock image July 1, 2024, Paraguay. In this photo illustration, antibiotic tablets (amoxicillin and norfloxacin), activated charcoal and flu medicine are seen next to a measuring tape. Some medications can cause side effects that, over time, can cause weight gai

July 1, 2024, Paraguay. In This Photo Illustration, Antibiotic Tablets (amoxicillin And Norfloxacin), Activated Charcoal And Flu Medicine Are Seen Next To A Measuring Tape. Some Medications Can Cause Side Effects That, Over Time, Can Cause Weight Gai

Image, 4.54MB, 4810 × 3207 jpg
stock image Prague, Czech Republic - July 10 2024: JARDIANCE box of medication with EMPAGLIFLOZIN active substance by BOEHRINGER INGELHEIM, used for treatment of type 2 diabetes and cardiovascular risk reduction.

Prague, Czech Republic - July 10 2024: JARDIANCE Box Of Medication With EMPAGLIFLOZIN Active Substance By BOEHRINGER INGELHEIM, Used For Treatment Of Type 2 Diabetes And Cardiovascular Risk Reduction.

Image, 2.1MB, 4032 × 3024 jpg
stock image Prague, Czech Republic - July 10 2024: JARDIANCE box of medication with EMPAGLIFLOZIN active substance by BOEHRINGER INGELHEIM, used for treatment of type 2 diabetes and cardiovascular risk reduction.

Prague, Czech Republic - July 10 2024: JARDIANCE Box Of Medication With EMPAGLIFLOZIN Active Substance By BOEHRINGER INGELHEIM, Used For Treatment Of Type 2 Diabetes And Cardiovascular Risk Reduction.

Image, 2.88MB, 4032 × 3024 jpg
stock image Prague, Czech Republic - July 10 2024: XIGDUO box of medication with DAPAGLIFLOZIN and METFORMIN active substances by ASTRAZENECA, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.49MB, 4032 × 3024 jpg
stock image Prague, Czech Republic - July 10 2024: XIGDUO box of medication with DAPAGLIFLOZIN and METFORMIN active substances by ASTRAZENECA, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.53MB, 3024 × 4032 jpg
stock image July 1, 2024, Paraguay. In this photo illustration, a woman takes her waist measurements with a measuring tape. According to the World Health Organization (WHO), 12.5% of the world's population is considered obese.

July 1, 2024, Paraguay. In This Photo Illustration, A Woman Takes Her Waist Measurements With A Measuring Tape. According To The World Health Organization (WHO), 12.5% Of The World's Population Is Considered Obese.

Image, 7.25MB, 6240 × 4160 jpg
stock image Prague, Czech Republic - July 10 2024: XIGDUO box of medication with DAPAGLIFLOZIN and METFORMIN active substances by ASTRAZENECA, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.25MB, 4032 × 3024 jpg
stock image Prague, Czech Republic - July 10 2024: JARDIANCE box of medication with EMPAGLIFLOZIN active substance by BOEHRINGER INGELHEIM, used for treatment of type 2 diabetes and cardiovascular risk reduction.

Prague, Czech Republic - July 10 2024: JARDIANCE Box Of Medication With EMPAGLIFLOZIN Active Substance By BOEHRINGER INGELHEIM, Used For Treatment Of Type 2 Diabetes And Cardiovascular Risk Reduction.

Image, 2.98MB, 4032 × 3024 jpg
stock vector International Tea Day.May 1st.White mug with tea bag on cream colored cup and table.

International Tea Day.May 1st.White Mug With Tea Bag On Cream Colored Cup And Table.

Vector, 9.21MB, 8333 × 6250 eps
stock image Prague, Czech Republic - July 10 2024: XIGDUO box of medication with DAPAGLIFLOZIN and METFORMIN active substances by ASTRAZENECA, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.2MB, 4032 × 3024 jpg
stock image Prague, Czech Republic - July 10 2024: XIGDUO box of medication with DAPAGLIFLOZIN and METFORMIN active substances by ASTRAZENECA, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.31MB, 4032 × 3024 jpg
stock image Prague, Czech Republic - July 10 2024: JARDIANCE box of medication with EMPAGLIFLOZIN active substance by BOEHRINGER INGELHEIM, used for treatment of type 2 diabetes and cardiovascular risk reduction.

Prague, Czech Republic - July 10 2024: JARDIANCE Box Of Medication With EMPAGLIFLOZIN Active Substance By BOEHRINGER INGELHEIM, Used For Treatment Of Type 2 Diabetes And Cardiovascular Risk Reduction.

Image, 2.05MB, 4032 × 3024 jpg
stock image Prague, Czech Republic - July 10 2024: JARDIANCE box of medication with EMPAGLIFLOZIN active substance by BOEHRINGER INGELHEIM, used for treatment of type 2 diabetes and cardiovascular risk reduction.

Prague, Czech Republic - July 10 2024: JARDIANCE Box Of Medication With EMPAGLIFLOZIN Active Substance By BOEHRINGER INGELHEIM, Used For Treatment Of Type 2 Diabetes And Cardiovascular Risk Reduction.

Image, 2.92MB, 4032 × 3024 jpg
stock image Prague, Czech Republic - July 10 2024: XIGDUO box of medication with DAPAGLIFLOZIN and METFORMIN active substances by ASTRAZENECA, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.47MB, 4032 × 3024 jpg
stock image Prague, Czech Republic - July 10 2024: XIGDUO box of medication with DAPAGLIFLOZIN and METFORMIN active substances by ASTRAZENECA, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.52MB, 3024 × 4032 jpg
stock image Prague, Czech Republic - July 10 2024: JARDIANCE box of medication with EMPAGLIFLOZIN active substance by BOEHRINGER INGELHEIM, used for treatment of type 2 diabetes and cardiovascular risk reduction.

Prague, Czech Republic - July 10 2024: JARDIANCE Box Of Medication With EMPAGLIFLOZIN Active Substance By BOEHRINGER INGELHEIM, Used For Treatment Of Type 2 Diabetes And Cardiovascular Risk Reduction.

Image, 2.12MB, 4032 × 3024 jpg
stock image Prague, Czech Republic - July 10 2024: XIGDUO box of medication with DAPAGLIFLOZIN and METFORMIN active substances by ASTRAZENECA, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.26MB, 4032 × 3024 jpg
stock image Prague,Czech Republic-August 10 2024: NUSTENDI box of tablets with BEMPEDOIC ACID and EZETIMIBE active substances, used for treatment of hyperlipidemia, cholesterol lowering.

Prague,Czech Republic-August 10 2024: NUSTENDI Box Of Tablets With BEMPEDOIC ACID And EZETIMIBE Active Substances, Used For Treatment Of Hyperlipidemia, Cholesterol Lowering.

Image, 2.45MB, 4032 × 3024 jpg
stock image Prague,Czech Republic-August 10 2024: NUSTENDI box of tablets with BEMPEDOIC ACID and EZETIMIBE active substances, used for treatment of hyperlipidemia, cholesterol lowering.

Prague,Czech Republic-August 10 2024: NUSTENDI Box Of Tablets With BEMPEDOIC ACID And EZETIMIBE Active Substances, Used For Treatment Of Hyperlipidemia, Cholesterol Lowering.

Image, 2.36MB, 4032 × 3024 jpg
stock image July 1, 2024, Paraguay. In this photo illustration, a woman takes her waist measurements with a measuring tape. According to the World Health Organization (WHO), 12.5% of the world's population is considered obese.

July 1, 2024, Paraguay. In This Photo Illustration, A Woman Takes Her Waist Measurements With A Measuring Tape. According To The World Health Organization (WHO), 12.5% Of The World's Population Is Considered Obese.

Image, 7.41MB, 6240 × 4160 jpg
stock image Prague, Czech Republic - July 10 2024: XIGDUO box of medication with DAPAGLIFLOZIN and METFORMIN active substances by ASTRAZENECA, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.37MB, 4032 × 3024 jpg
stock image Prague, Czech Republic - July 10 2024: XIGDUO box of medication with DAPAGLIFLOZIN and METFORMIN active substances by ASTRAZENECA, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.51MB, 3024 × 4032 jpg
stock image Prague, Czech Republic - July 10 2024: XIGDUO box of medication with DAPAGLIFLOZIN and METFORMIN active substances by ASTRAZENECA, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.34MB, 3024 × 4032 jpg
stock image Prague, Czech Republic - July 10 2024: XIGDUO box of medication with DAPAGLIFLOZIN and METFORMIN active substances by ASTRAZENECA, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.33MB, 3024 × 4032 jpg
stock image Prague, Czech Republic - July 10 2024: XIGDUO box of medication with DAPAGLIFLOZIN and METFORMIN active substances by ASTRAZENECA, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.48MB, 3024 × 4032 jpg
stock image Prague, Czech Republic - July 10 2024: XIGDUO box of medication with DAPAGLIFLOZIN and METFORMIN active substances by ASTRAZENECA, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.5MB, 3024 × 4032 jpg
stock image Prague, Czech Republic - July 10 2024: XIGDUO box of medication with DAPAGLIFLOZIN and METFORMIN active substances by ASTRAZENECA, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.38MB, 3024 × 4032 jpg
stock image HDL High Density Lipoprotein is shown using a text

HDL High Density Lipoprotein Is Shown Using A Text

Image, 5.74MB, 4779 × 3384 jpg
stock image Prague, Czech Republic - July 10 2024: XIGDUO box of medication with DAPAGLIFLOZIN and METFORMIN active substances by ASTRAZENECA, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.14MB, 4032 × 3024 jpg
Page 1 >> Next